News Par Views: After Listing At A Premium Of 20% Mankind Pharmas Management Explains Growth Plans | Anil Singhvi

What is the business model and future plan of Mankind Pharma? Where will the money raised from IPO be used? Know from the company's Chairman, Ramesh Juneja and VC & MD Rajeev Juneja. Watch Anil Singhvi's exclusive conversation with Mankind Pharma's Chairman, Ramesh Juneja and VC & MD Rajeev Juneja after a strong listing at a premium of 20%.